Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reciprocal interactions among Cobll1, PACSIN2, and SH3BP1 regulate drug resistance in chronic myeloid leukemia.
Park K, Yoo HS, Oh CK, Lee JR, Chung HJ, Kim HN, Kim SH, Kee KM, Kim TY, Kim M, Kim BG, Ra JS, Myung K, Kim H, Han SH, Seo MD, Lee Y, Kim DW. Park K, et al. Among authors: kim h, kim dw, kim sh, kim ty, kim bg, kim hn, kim m. Cancer Med. 2022 Nov;11(21):4005-4020. doi: 10.1002/cam4.4727. Epub 2022 Mar 30. Cancer Med. 2022. PMID: 35352878 Free PMC article.
BCR-ABL1 transcript levels at 4 weeks have prognostic significance for time-specific responses and for predicting survival in chronic-phase chronic myeloid leukemia patients treated with various tyrosine kinase inhibitors.
Song HY, Noh H, Choi SY, Lee SE, Kim SH, Kee KM, Yoo HL, Lee MY, Kang KH, Suh JH, Yang SY, Jang EJ, Lee JI, Kim DW. Song HY, et al. Among authors: kim dw, kim sh. Cancer Med. 2018 Oct;7(10):5107-5117. doi: 10.1002/cam4.1753. Epub 2018 Aug 31. Cancer Med. 2018. PMID: 30171671 Free PMC article.
Cobll1: A new player in CML.
Kim H, Kim DW, Myung K. Kim H, et al. Among authors: kim dw. Oncotarget. 2017 Oct 10;8(53):90626-90627. doi: 10.18632/oncotarget.21705. eCollection 2017 Oct 31. Oncotarget. 2017. PMID: 29207587 Free PMC article. No abstract available.
Baseline BCR-ABL1 transcript type of e13a2 and large spleen size are predictors of poor long-term outcomes in chronic phase chronic myeloid leukemia patients who failed to achieve an early molecular response after 3 months of imatinib therapy.
Lee SE, Choi SY, Kim SH, Song HY, Yoo HL, Lee MY, Hwang HJ, Kang KH, Kee KM, Jang EJ, Kim DW. Lee SE, et al. Among authors: kim dw, kim sh. Leuk Lymphoma. 2018 Jan;59(1):105-113. doi: 10.1080/10428194.2017.1320711. Epub 2017 May 25. Leuk Lymphoma. 2018. PMID: 28540759
5,165 results